妊娠高血压疾病的血液动力学导向治疗:系统性审查
Anne-Christin Loheit1, Charlotte Lößner2, Ekkehard Schleussner2
1Member of the Center for Early Pregnancy and Reproductive Health (CEPRE), Obstetric Clinic, University Hospital Jena, Am Uniklinikum 1, 07747, Jena, Germany. Anne-Christin.Loheit@med.uni-jena.de.
Archives of gynecology and obstetrics
|January 14, 2026
概括
由母亲血液动力学指导的个性化抗高血压疗法显著改善了血压控制,并减少了高血压疾病的妊娠并发症. 这种方法提供了一个量身定制的治疗策略,以改善母亲和胎儿的结果.
科学领域:
- 产科和妇科 产科和妇科
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 尽管正在进行研究,但妊娠中高血压疾病仍然是孕产妇死亡的主要原因.
- 目前的抗高血压疗法主要集中在症状管理和血压控制上,往往忽视了个体血液动力学变异.
- 血液动力学引导的方法通过解决潜在的病理生理学来提供个性化治疗.
研究的目的:
- 审查血液动力学导向的抗高血压疗法用于妊娠高血压疾病.
- 介绍最近干预试验的发现,评估这种个性化方法.
主要方法:
- 在PubMed,CENTRAL和谷歌学者中进行文献搜索,截至2024年5月.
- 包括使用母体血液动力学参数 (心脏输出,外周总血管阻力) 来指导抗高血压治疗的干预研究.
- 专注于患有高血压疾病的孕妇或患有子宫前的孕妇.
主要成果:
- 五项研究符合纳入标准,所有这些研究都表明,通过血液动力学匹配的抗高血压药物改善了血压控制.
- 个性化治疗显著降低了怀孕并发症的妇女与低或高动态循环.
- 即使在有先兆子史的患者中也观察到积极的结果.
结论:
- 血液动力学导向的抗高血压疗法可以提高高血压怀孕中母亲和胎儿的结果.
- 需要进一步的安慰剂对照试验来最终评估这种治疗策略的疗效.
相关概念视频
Hypertension V: Nursing Management
355
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
355
Hypertension IV: Drug Therapy and Lifestyle Modifications
618
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
618
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
438
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
438
Hypertension III: Clinical Manifestations and Diagnostic Studies
465
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
465
Hypertension and Regulation of Blood Pressure
3.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K


